B2B only. For licensed importers and distributors. Tender authorities and healthcare institutions are also served. Not for retail or patient supply.  ·  Compliance statement
Home/Insights/Product comparison
Product comparison

Human albumin 5% vs 20%: what's the difference

Same protein, two concentrations — and a tender line that must not be merged. The percentage is not a minor detail; it decides the colloid osmotic effect and the clinical setting, and a quotation that swaps one strength for the other has not answered the specification.

Two presentations of the same plasma protein, and a procurement mistake that is easy to make: treating human albumin 5% and 20% as if they were two sizes of the same line, interchangeable by volume. They are not. The concentration changes what the product does and where it is used, and a buyer who merges the two lines has ordered a product that does not answer the tender.

This comparison is written for licensed importers, distributors and tender authorities — the people who have to put the right strength on the right line, with the right approval number. It describes what the concentration means and how the two strengths differ, and ends with a decision guide for the procurement side.

The one-sentence difference

The percentage is the albumin protein concentration in the solution. A 5% solution is a lower-concentration albumin, while a 20% solution is a higher-concentration albumin. The higher concentration exerts a stronger colloid osmotic effect, which is why the two strengths are used in different clinical settings and are not interchangeable.

Side-by-side comparison

Dimension Human albumin 5% Human albumin 20%
Concentration 5% albumin protein solution 20% albumin protein solution
Source Fractionated from pooled human plasma Fractionated from pooled human plasma
Colloid osmotic effect Lower Higher
Presentation (wanyoda) Not yet listed in the wanyoda portfolio 5 g / 25 ml · 10 g / 50 ml
Dosage form Solution for infusion Solution for infusion
Storage 2–8 °C, protected from light 2–8 °C, protected from light
Approval number (wanyoda) — (product line not yet listed) NMPA S10940011 · S10940012
Manufacturer (wanyoda) — China Resources Boya

The approval number makes the point in a single line: the two concentrations are different registered products with different 国药准字 numbers. A quotation that presents the 20% number against a 5% line is a mismatch, not a substitution.

Why the difference matters at procurement

The distinction is not academic, and it shows up in three places the buying side has to get right.

Separate tender lines

Albumin 5% and 20% are specified for different clinical settings, so they appear as separate lines in a tender and in the essential-medicine and reimbursement frameworks of most markets. They are not interchangeable within a line, and they are not fungible units of "albumin".

Separate registration dossiers

Each concentration holds its own registration certificate and its own batch release pathway. The dossier that registers the 20% solution does not register the 5% solution, and the import licence in the destination market names the specific strength. Mixing the two at the dossier stage delays the whole file.

Same logistics, different paperwork

Both move at 2–8 °C, protected from light, so a single validated cold chain can serve both. But the batch release certificate, the certificate of analysis and the approval reference are strength-specific. One cold chain, two document sets.

How to decide which one you need

The decision belongs to the specification, not to the buyer's preference. The question that resolves it is the concentration named in the tender or the purchase request.

  • If the requirement names a 5% solution, quote the 5% line — and confirm the strength with the manufacturer if it is not yet in your supplier's portfolio.
  • If the requirement names a 20% solution, quote the 20% line.
  • If the requirement is ambiguous, stop and ask for the named concentration before quoting — the two strengths are not alternatives, and guessing is how a wrong order is placed.

Where the two genuinely do overlap is on the supplier side: both concentrations come from the same plasma fractionation platform, so a single manufacturer can typically cover both lines — but only the strengths that are actually registered and listed.

Frequently asked questions

What is the difference between albumin 5% and 20%?

The difference is concentration. Albumin 5% is a lower-concentration solution, while albumin 20% is a higher-concentration solution. The concentration affects the colloid osmotic effect and the clinical setting each strength is used for, so the two are separate tender lines and are not interchangeable.

Which concentration should a tender specify?

It depends on the clinical indication named in the tender, not on price. The strength must match the specification; a quotation that swaps one concentration for the other does not answer the requirement. Confirm the named strength before quoting.

Do albumin 5% and 20% need the same cold chain?

Yes, both are stored and shipped at 2–8 °C protected from light. The cold-chain and storage requirements are the same regardless of concentration.

Does wanyoda supply both concentrations?

wanyoda currently supplies human albumin 20% from China Resources Boya, presented at 5 g / 25 ml and 10 g / 50 ml. A 5% concentration is not yet listed in the portfolio. Contact us for the latest product status.

Is the 20% solution more concentrated than the 5%?

Yes. The percentage refers to the albumin protein concentration in the solution. A 20% solution contains a higher concentration of albumin protein per volume than a 5% solution, which is why the two are used in different clinical settings and are not interchangeable.

Where to go next

Sourcing

Specify the right product on the right line.

Tell us the concentration and destination market, and we will confirm the matching product, approval reference and registration dossier.